Cassandra Pierre is an Infectious Disease physician affiliated with Boston Medical Center. OpenAlex indexes 33 publications with 458 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
725 Albany Street
Shapiro 9, Suite B
Boston, MA 021182526
Telephone
617-414-4290Registry record last updated 12 May 2014.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20212 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
36.6%Statin11.8%Rosuvastatin Calcium100%Part D<11 patientsACE inhibitor9.5%Lisinopril-Hydrochlorothiazide100%Part D<11 patients+ 2 more classes in this area
Anti-infectives
29.8%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor11.8%Juluca52%Tivicay48%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor8.8%Descovy100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
16%H2 blocker6.1%Famotidine100%Part D<11 patientsProton pump inhibitor5%Pantoprazole Sodium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- P-1083. Implementation of a Sustainable Process for Mupirocin Decolonization across Adult ICUs in an Urban Safety Net Hospital
Open Forum Infectious Diseases
2026 - Implementation strategies for sustainability of mupirocin decolonization across adult ICUs in an urban safety net hospital
American Journal of Infection Control
2026 - CBNPC avancés présentant un contrôle prolongé sous immunothérapie : Cohorte BREATH
Revue des Maladies Respiratoires
2025 - Addressing Unmet PrEP Needs in Women: Impact of a Laboratory-Driven Protocol at an Urban, Essential Hospital
Open Forum Infectious Diseases
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Alice Jacobs, MD
Boston Medical Center
Carlos Kase, MD
Boston Medical Center
Sushrut Waikar, MD
Boston Medical Center
Geoffrey Oxnard, MD
Boston Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”